Lemaitre Vascular (LMAT) Invested Capital (2020 - 2021)

Lemaitre Vascular's (LMAT) quarterly Invested Capital came in at $3.0 million in Q2 2021, up 50.0% year-on-year from $2.0 million in Q2 2020, and up 20.0% on a QoQ basis from $2.5 million in Q4 2020.

Lemaitre Vascular (LMAT) Invested Capital (2020 - 2021) Analysis & Trends

Lemaitre Vascular (LMAT) has 2 years of Invested Capital data on file, last reported at $3.0 million in Q2 2021.

  • On a quarterly basis, Invested Capital rose 50.0% year-over-year to $3.0 million in Q2 2021; TTM through Mar 2022 was $3.0 million, a 55.56% decrease from a year earlier, with the FY2020 full-year figure at $2.5 million, changed N/A from the prior year.
  • Invested Capital for Q2 2021 stood at $3.0 million, up from $2.5 million in the prior quarter.
  • Over the last five years, Invested Capital for LMAT reached as high as $3.0 million in Q2 2021 and fell as low as $2.0 million in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn -
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn -
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn 2.57 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn 77.00 Mn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 259.93 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn -
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn 598.90 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 208.00 Mn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn -
10 Lemaitre Vascular 2.22 Bn 1.86 Bn 48.40 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2021 3.00 Mn
Dec 31, 2020 2.50 Mn
Sep 30, 2020 2.25 Mn
Jun 30, 2020 2.00 Mn